Results 21 to 30 of about 18,595 (356)

Penggunaan Jamu Pada Pasien Hiperlipidemia Berdasarkan Data Rekam Medik, Di Beberapa Fasilitas Pelayanan Kesehatan Di Indonesia [PDF]

open access: yes, 2015
Hyperlipidemias are disorders which are manifested by elevation of blood lipid, such as total cholesterol and/or triglyceride above the normal level.
Gitawati, R. (Retno)   +2 more
core   +2 more sources

APPROACHES TO THE LIPID METABOLISM GENES POLYMORPHYSM ANALYSIS IN SCREENING FOR ATHEROSCLEROSIS RISK FACTORS

open access: yesРоссийский кардиологический журнал, 2014
The review concerns he etiology of polygenic hyperlipidemias. The most prominent and prevalent in more than 1% of inhabitants genetic markers are discussed.
N. V. Koch   +2 more
doaj   +1 more source

Dislipidemia na infância: Uma revisão de literatura

open access: yesResidência Pediátrica, 2023
OBJECTIVE: To describe the state of the art in the assessment and management of pediatric patients with dyslipidemia. METHODS: The review was carried out using the PubMed database, taking into account articles published between 2005 and 2021.
Gabriela de Lima Carlesso   +5 more
doaj   +1 more source

Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease [PDF]

open access: yes, 2015
Background Screening programmes can potentially identify people at high cardiovascular risk and reduce cardiovascular disease (CVD) morbidity and mortality. However, there is currently not enough evidence showing clear clinical or economic benefits of
Clarke, Aileen   +4 more
core   +4 more sources

Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women [PDF]

open access: yes, 2001
We tested whether trans fatty acids and saturated fatty acids had different effects on flow-mediated vasodilation (FMD), a risk marker of coronary heart disease (CHD). Consumption of trans fatty acids is related to increased risk of CHD, probably through
Bots, M.L., Katan, M.B., Roos, N.M., de
core   +2 more sources

Adding ezetimibe to statin therapy: latest evidence and clinical implications

open access: yesDrugs in Context, 2018
Background: Statins are the hypolipemic treatment of choice for hyperlipidemia with confirmed atherosclerotic cardiovascular disease (ASCVD) protective effect, proven even in normolipemic patients.
Marija Vavlukis, Ana Vavlukis
doaj   +1 more source

Selenium supplementation for the primary prevention of cardiovascular disease [PDF]

open access: yes, 2013
Background: Selenium is a key component of a number of selenoproteins which protect against oxidative stress and have the potential to prevent chronic diseases including cardiovascular disease (CVD).
Clarke, Aileen   +5 more
core   +1 more source

The changes in cardiovascular disease risk factors after the implementation of the package of essential non-communicable disease control [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research
Introduction: The Package of Essential Non-Communicable (PEN) Disease Control was implemented in the primary healthcare system to manage cardiovascular disease (CVD) risk factors in Iran. This study aimed to evaluate the status of CVD risk factor control
Ali Reza Pouramini   +2 more
doaj   +1 more source

Advanced Research of Abdominal Aortic Aneurysms on Metabolism

open access: yesFrontiers in Cardiovascular Medicine, 2021
Abdominal aortic aneurysm (AAA) is a cardiovascular disease with a high risk of death, seriously threatening the life and health of people. The specific pathogenesis of AAA is still not fully understood. In recent years, researchers have found that amino
Yangfeng Hou   +6 more
doaj   +1 more source

Hyperlipidemias and dietary patterns: transversal study of japanese brazilians [PDF]

open access: yes, 2007
This study aimed at evaluating the association between hyperlipidemia and dietary patterns of Japanese Brazilians with and without hypothyroidism from Bauru, city in the State of São Paulo.
Bevilacqua, Marselle Rodrigues   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy